Candel Therapeutics (CADL) Net Cash Flow: 2020-2023
Historic Net Cash Flow for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to -$7.6 million.
- Candel Therapeutics' Net Cash Flow fell 6.25% to -$7.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.6 million, marking a year-over-year decrease of 171.90%. This contributed to the annual value of $67.2 million for FY2024, which is 294.09% up from last year.
- Latest data reveals that Candel Therapeutics reported Net Cash Flow of -$7.6 million as of Q4 2023, which was up 15.05% from -$8.9 million recorded in Q3 2023.
- Candel Therapeutics' 5-year Net Cash Flow high stood at $64.1 million for Q3 2021, and its period low was -$10.8 million during Q1 2023.
- In the last 3 years, Candel Therapeutics' Net Cash Flow had a median value of -$7.2 million in 2022 and averaged $30,000.
- In the last 5 years, Candel Therapeutics' Net Cash Flow soared by 2,964.06% in 2021 and then crashed by 192.37% in 2023.
- Candel Therapeutics' Net Cash Flow (Quarterly) stood at $16.8 million in 2020, then slumped by 134.19% to -$5.7 million in 2021, then fell by 24.09% to -$7.1 million in 2022, then decreased by 6.25% to -$7.6 million in 2023.
- Its last three reported values are -$7.6 million in Q4 2023, -$8.9 million for Q3 2023, and -$7.4 million during Q2 2023.